A novel estrogen receptor gper inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298: H16 -H23, 2010. First published October 30, 2009 doi:10.1152/ajpheart.00588.2009.-Several studies have recently demonstrated that G protein-coupled receptor 30 (GPER) can directly bind to estrogen and mediate its action. We investigated the role and the mechanism of estrogen-induced cardioprotection after ischemia-reperfusion using a specific GPER agonist G1. Isolated hearts from male mice were perfused using Langendorff technique with oxygenated (95% O2 and 5% CO2) Krebs Henseleit buffer (control), with G1 (1 M), and G1 (1 M) together with extracellular signal-regulated kinase (Erk) inhibitor PD-98059 (5M). After 20 min of perfusion, hearts were subjected to 20 min global normothermic (37°C) ischemia followed by 40 min reperfusion. Cardiac function was measured, and myocardial necrosis was evaluated by triphenyltetrazolium chloride staining at the end of the reperfusion. Mitochondria were isolated after 10 min of reperfusion to assess the Ca 2ϩ load required to induce mitochondria permeability transition pore (mPTP) opening. G1-treated hearts developed better functional recovery with higher rate pressure product (RPP, 6140 Ϯ 264 vs. 2,640 Ϯ 334 beats ⅐ mmHg Ϫ1 ⅐ min Ϫ1 , P Ͻ 0.05). The infarct size decreased significantly in G1-treated hearts (21 Ϯ 2 vs. 46 Ϯ 3%, P Ͻ 0.001), and the Ca 2ϩ load required to induce mPTP opening increased (2.4 Ϯ 0.06 vs. 1.6 Ϯ 0.11 M/mg mitochondrial protein, P Ͻ 0.05) compared with the controls. The protective effect of G1 was abolished in the presence of PD-98059 [RPP: 4,120 Ϯ 46 beats ⅐ mmHg Ϫ1 ⅐ min Ϫ1 , infarct size: 53 Ϯ 2%, and Ca 2ϩ retention capacity: 1.4 Ϯ 0.11 M/mg mitochondrial protein (P Ͻ 0.05)]. These results suggest that GPER activation provides a cardioprotective effect after ischemia-reperfusion by inhibiting the mPTP opening, and this effect is mediated by the Erk pathway.
Recent works have demonstrated the existence of a novel G protein coupled receptor 30, GPR30, here referred as GPER, that can bind directly to estrogen and mediates estrogen action (1, 6, 28, 34) . Estrogen rapidly activates adenylyl cyclase and the mitogen-activated protein kinases, extracellular signal-regulated kinase (Erk)-1and Erk-2, through GPER, resulting in mobilization of intracellular Ca 2ϩ concentration store in cancer cells (12, 13) . GPER is an integral membrane protein with high affinity for estrogen (1, 11, 31, 32) . GPER seems to play only an important role in the rapid estrogen nongenomic signaling events widely observed in cells and tissues (27, 32) . The activation of GPER by estrogen resulted in intracellular Ca 2ϩ mobilization and synthesis of phosphatidylinositol 3,4,5-trisphosphate in the nucleus (32, 35) .
The potential role and the mechanism of GPER activation in cardioprotection is an important topic under investigation. A recent report showed that GPER activation improves functional recovery and reduces infarct size after ischemia in isolated rat hearts following ischemia and reperfusion and that this protective effect was blocked by the phosphatidylinositol 3-kinase inhibitor wortmannin (10) .
The opening of the mitochondria permeability transition pore (mPTP) appears to be a pivotal event in cell death after ischemia-reperfusion (38) . During myocardial ischemia, the mPTP remains closed, and it only will open within the first few minutes after myocardial reperfusion in response to mitochondrial Ca 2ϩ overload, oxidative stress, and ATP depletion (24) . The inhibition of mPTP opening during the reperfusion exerts myocardial protection (20) . However, the upstream mechanisms regulating mPTP opening in the setting of ischemiareperfusion injury remain to be determined. The aims of this study are to explore in isolated hearts from mice after ischemia-reperfusion the role of GPER activation using G1, a specific GPER agonist (3), in 1) cardioprotection (cardiac function and infarct size), 2) the involvement of the mPTP opening, and 3) the participation of Erk activation.
METHODS

Animals
Male mice wild types (C57BL/6ScSn), 8 -12 
Langendorff Preparation
Mice were anesthetized by intraperitoneal injection of pentobarbital sodium (50 mg/kg); heparin (200 IU/kg) was injected to prevent blood coagulation. Hearts were removed and immediately arrested in cold (4°C) Krebs Henseleit bicarbonate buffer solution (KH) (in mM): 11.1 glucose, 118 NaCl, 4.7 KCl, 1.2 MgSO 4, 1.2 KH2PO4, 25.0 NaHCO3, and 2 CaCl2 at pH 7.4. The aorta was rapidly cannulated and the heart retrograde-perfused at a constant rate (3 ml/min) in the Langendorff mode using KH solution (control) or with the addition of G1 (1 M) (Merck, Frankfurt, Germany). G1 is 1-{4-(6-bromobenzo [1, 3] dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl}-ethanone, a cell-permeable, nonsteroidal, dihydroquinoline compound that acts as a high-affinity agonist for GPER. G1 (1 M) should selectively activate GPER without any significant action on ER␣ and ER␤ (3). To investigate the involvement of Erk pathway, G1 (1 M) together with ERK inhibitor PD-98059 (5 M) was used. PD-98059 was obtained from Invitrogen. The buffer was bubbled with 95% O 2-5% CO2 at 37°C. After 20 min of equilibration, global normothermic ischemia was induced by clamping the aorta for 20 min. Heart function recovery and infarct size were measured during or at the end of a 40-min period of reperfusion after the ischemia, respectively. Mitochondria Ca 2ϩ retention capacity (CRC) was measured after 10 min of reperfusion to measure at an earlier time the initial mitochondria dysfunction preceding cardiac necrosis measured as the infarct size.
Heart Functional Measurements
Left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), and heart rate (HR) were recorded with a pressure transducer (1.4F Millar SPR-671) directly inserted in the left ventricle (LV) after a left atrial incision exposing the mitral annulus (Power Lab; AD Instruments). The left ventricular developed pressure (LVDP) and rate pressure product (RPP) were calculated as LVDP ϭ LVSP Ϫ LVEDP, RPP ϭ HR ϫ LVDP. The maximum rate of rise of the LV contraction velocity (dP/dt max) and the maximum isovolumetric rate of relaxation (ϪdP/dtmin) were directly calculated from the recordings.
Myocardium Infarct Size
Myocardial infarct was assessed by measurement of the infarct size using triphenyltetrazolium chloride (TTC) staining. At the end of reperfusion, the hearts were cut into four transverse slices, parallel to the atrioventricular groove. After removing the right ventricular tissue, heart slices were weighed and incubated for 10 min in 1% TTC in Tris⅐HCl (pHϭ7.4) at 37°C followed by fixation with 4% paraformaldehyde. This procedure differentiates the infarcted (pale) from viable (brick red) myocardial tissue. The slices were photographed using digital microscopic imaging. Extent of the area of necrosis was quantified by computerized planimetry with Adobe Photoshop. Total area of necrosis was calculated and expressed as the percentage of total LV area.
Ca 2ϩ -Induced Mitochondrial Permeability Transition
Preparation of isolated mitochondria. Preparation of mitochondria was adapted from a previously described procedure (4). The preparation procedure was carried out at 4°C. Myocardial sections (ϳ0.15-0.22 g) were placed in isolation buffer A (in mM: 70 sucrose, 210 mannitol, 1 EDTA, and 50 Tris ⅐ HCl, pH 7.4). The tissue was finely minced with scissors and homogenized in the same buffer A (1 ml buffer/0.1 g of tissue) using Kontes and Potter-Elvehjem tissue grinders. The homogenate was centrifuged at 1,300 g for 3 min, and the supernatant was filtered through cheesecloth and centrifuged at 10,000 g for 10 min. The mitochondrial pellet was resuspended in isolation buffer B (in mM, 70 sucrose, 210 mannitol, 0.1 EDTA, and 50 Tris ⅐ HCl, pH 7.4). Protein concentration was assayed using the Bradford method.
CRC. The installation of mPTP opening was assessed following in vitro Ca 2ϩ overload as previously described (15) . Free Ca 2ϩ concentration outside the mitochondria was recorded with 0.5 M calcium green-5N (Invitrogen) using excitation and emission wavelengths set at 500 and 530 nm, respectively. Isolated mitochondria (500 g of protein) were suspended in 2 ml buffer C (in mM, 150 sucrose, 50 KCl, 2 KH 2PO4, 5 succinic acid, and 20 Tris ⅐ HCl, pH 7.4). Samples were preincubated for 90 s in the spectrofluorometer cell, and CaCl2 pulses (200 pmol, 2 l of 100 nM stock solution) were applied every 60 s in the spectrofluorometer cell (2 ml containing isolated mitochondria at 250 g/ml protein) leading to 100 nM Ca 2ϩ without the mitochondria uptake. The Ca 2ϩ pulses induce a peak of extramitochondrial Ca 2ϩ concentration that returns to near-baseline level as Ca 2ϩ enters the mitochondrial matrix via the uptake by the Ca 2ϩ uniporter. With increasing Ca 2ϩ loading, the extramitochondrial Ca 2ϩ concentration starts accumulating, reflecting a lower capacity for mitochondria Ca 2ϩ uptake that is followed by a sustained Ca 2ϩ increase indicating a massive release of the mitochondria Ca 2ϩ by the mPTP opening. The CRC was defined as the amount of Ca 2ϩ required to trigger this massive Ca 2ϩ release that is used here as an indicator of the mPTP sensitivity to Ca 2ϩ . CRC is expressed as micromolar of CaCl2 per milligram of mitochondrial protein.
Western Blot
Whole cell heart lysates were prepared by homogenizing the heart in (in mM) 50 NaCl, 25 Tris ⅐ HCl, 2% Nonidet P-40, 0.2% SDS, and 0.5% sodium deoxycholate (pH 7.4) supplemented with Protease Inhibitor cocktail (Roche). The samples were centrifuged at 3,000 g for 10 min, and the supernatants were collected. For electrophoresis, 50 g of protein were loaded on a 10% Tris ⅐ HCl SDS polyacrylamide Fig. 1 . Expression of G protein-coupled receptor 30 (GPER) transcript and protein levels in the heart. A: fluorescence-cycle number curves for glyceraldehydes-3-phosphate dehydrogenase (GAPDH; F), GPER (E), and Kv4.3 (ᮀ) in total RNA from mouse heart (means Ϯ SE, n ϭ 3 hearts measured independently and by triplicate each). B: Western blot analysis showing GPER expression in whole cell lysate. AU, arbitraty units; qRT-PCR, quantitative RT-PCR; ; Ab, antibody; Ab ϩ Ag, antibody ϩ antigen (3 hearts measured independently and by duplicate each).
gel. Protein was electrotransferred to a nitrocellulose membrane and then blocked with 5% nonfat dry milk in 20 mM of TBS with 0.1% Tween. After blocking, the membrane was incubated overnight at 4°C with either anti-GPER primary antibody (Ab) (sc-48524, lot F0208, 1:200 dilution; Santa Cruz Biotechnology) or GPER Ab ϩ antigen (sc-48524 P, lot no. C2307, 10 times) and with the corresponding secondary Ab of 1:100,000 (Li-Cor) at room temperature. After washing three times, bands were visualized using an infrared fluorescence system (Odyssey Imaging System; Li-Cor).
Quantitative Real-Time PCR
Total RNA was isolated using Trizol (Invitrogen) and reverse transcribed with gene-specific primers for real-time PCR. The transcript level of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal reference gene.
Primers were as follows: GAPDH (forward primer 5Ј-TCCTGCAC-CACCAACTGCTTAG-3Ј, reverse primer 5Ј-GATGACCTTGCC-CACAGCCTTG-3Ј; AF106860); GPER (forward primer 5Ј-CCA-GAAGGTGAGCAGGCAGCAG-3Ј, reverse primer 5-CGAGCA-GAAGACGAGGTCTATCTC-3Ј, NM_029771), and Kv4.3 (forward primer 5Ј-CTTCATCCGCAGTGTGATGAG-3Ј, reverse primer 5Ј-TTGAAGATCCTGAAGACACGGAA-3Ј; AF107781). The reaction mixture without cDNA, or without reverse transcriptase, was used as negative controls.
Statistical Analysis
All values are expressed as means Ϯ SE. Comparisons among groups were performed with two-way ANOVA. Statistical significance of differences between groups was defined as a value of P Ͻ 0.05. Fig. 2 . Heart function recovery in the specific GPER agonist G1 and control group after ischemia-reperfusion. A and B: heart function recordings showing the left ventricular developed pressure (LVDP) and the maximum velocity of contraction and relaxation (dP/dt) in control (A) and with 1 M G1 (B). HH, Krebs Henseleit bicarbonate buffer solution. C-F: graphs representing the values before ischemia and their time course after ischemia-perfusion (time 0) of dP/dtmax (C), ϪdP/dtmin (D), rate pressure product (RPP) (E), and LVDP (F). Values are expressed as means Ϯ SE; *P Ͻ 0.05 vs. control (n ϭ 5-8/ group). Note that, in control and after G1 treatment, values before ischemia are very similar, whereas after ischemia-reperfusion heart functional recovery was dramatically improved by G1 treatment. G1 (1 M) activates GPER without a significant action on estrogen receptor ␣ and ␤ (3).
RESULTS
Expression of GPER Transcripts in Whole Heart Lysate
Quantitative real-time PCR experiments and Western blot analysis demonstrate that GPER is expressed in adult mouse heart. Figure 1A shows the fluorescence-cycle number curves for GAPDH, GPER, and Kv4.3, which is the molecular correlate of the fast transient repolarizing current in mouse heart. The housekeeping gene GAPDH transcript level (cycle threshold ϳ9) was more abundant when compared with GPER (cycle threshold ϳ21) and the ion channel Kv4.3 (cycle threshold ϳ18). These data are the mean of n ϭ 3, each mouse triplicate.
Western Blot Analysis
In agreement with transcript determinations, Western blot analysis demonstrates that anti-GPER Ab labels a predominant band of the expected molecular size (38 kDa) of GPER that are blocked when the anti-GPER Ab was preincubated overnight with GPER antigenic peptide (Fig. 1B) . This result indicates the presence of GPER in the heart. In summary, GPER levels in heart should be sufficient to modulate function. For Western blot, we have used n ϭ 3, each mouse in duplicate.
G1 Treatment Improves Heart Function After Ischemia-Reperfusion Injury
To investigate the role of GPER in cardioprotection, heart function was recorded in both control and G1 treatment to activate GPER. Figure 2 , A and B, shows examples of recording of isolated heart subjected to ischemia-reperfusion in an ex vivo model using the Langendorff system in the absence (control, A) and in the presence (B) of 1 M G1. We selected an ischemic period of 20 min that in the mouse model typically shows ϳ50 of infarct size in control conditions (see Fig. 3 ).
There was no difference in cardiac function in two groups before ischemia, since dP/dt max (Fig. 2C) , ϪdP/dt min (Fig. 2D) , RPP (Fig. 2E) , and LVDP (Fig. 2F) were similar. LV function after 40 min of reperfusion postischemia was significantly decreased from the baseline in control and G1-treated hearts. However, the functional recovery was significantly higher with G1 treatment (Fig. 2, C-F , and Table 1 ). In summary, heart functional parameters were similar in control and after G1 treatment and were much better in G1-treated hearts at all times after ischemia-reperfusion, which demonstrates that activation of GPER by G1 improves functional recovery after ischemiareperfusion.
Myocardial Infarct Size Reduction by G1 Treatment After Ischemia-Reperfusion Injury
There was no infarct size in nonischemic groups after 20 min of initial perfusion in the presence or absence of G1 (n ϭ 8/group). Figure 3A shows typical heart cross sections at different levels from control and G1 treatment after TTC staining. The red area represents the viable region and the white area the infarct size. The infarct size in the G1-treated group was reduced significantly by about one-half compared with control at the end of 40 min reperfusion (46 Ϯ 5 vs. 22 Ϯ 2%, P Ͻ 0.001, n ϭ 5-8/group, Fig. 3B ).
Increased Resistance by G1 Treatment of Ca 2ϩ
Induced mPTP Opening
To investigate the role of GPER activation in mitochondria function, we compared the sensitivity of mPTP opening by Values are means Ϯ SE; n ϭ 5-8 mice/group. G1, specific G proteincoupled receptor 30 agonist. Cardiac functional parameters recovery of left ventricular systolic pressure (LVSP); left ventricular end-diastolic pressure (LVEDP); left ventricular developed pressure (LVDP), and heart rate (HR) before ischemia (sham control and sham G1) and during different times of reperfusion in G1-treated and control group. *P Ͻ 0.05 vs. control.
Ca
2ϩ overload in isolated mitochondria from control and G1-treated hearts. Figure 4A shows the time course of Ca 2ϩ concentration in the solution surrounding the mitochondria. The initial Ca 2ϩ concentration in the buffer was set to Ca 2ϩ contaminant that declined after adding mitochondria due to the mitochondria Ca 2ϩ uptake. The initial sharp decay is because of a global reduction of the solution optical transmittance by the increase of turbidity after the mitochondria loading. The following slower phase before the addition of the Ca 2ϩ pulses reflects the rate of Ca 2ϩ uptake by the mitochondria. Note the faster Ca 2ϩ uptake with G1 treatment when compared with control that is already indicating a more robust Ca 2ϩ uptake after G1 treatment. Data in Fig. 4A indicate the establishment of mPTP opening defined when there is a beginning (represented by a two time increase of fluorescence spot in a minute) of spontaneous increase of Ca 2ϩ fluorescence after the preceding Ca 2ϩ pulse. In isolated mitochondria from control hearts, eight 100 nM Ca 2ϩ pulses were required to induce mPTP opening. The number of pulses to induce mPTP opening increased to 13 when using mitochondria from hearts perfused with 1 M G1 (Fig. 4A) .
In nonischemic control, CRC was 3.5 Ϯ 0.11 M/mg mitochondrial proteins. The CRC value was significantly reduced to 1.6 Ϯ 0.7 M/mg mitochondrial proteins after ischemia-reperfusion and it was recovered to 2.6 Ϯ 0.5 M/mg mitochondrial proteins after G1 treatment. As in functional studies, CRC values are very similar in nonischemic conditions in control and after ischemia-reperfusion after G1 treatment. Most importantly, G1 treatment after ischemia-reperfusion induced a much larger CRC value that is consistent with the inhibition of the mPTP opening and improved mitochondria function (Fig. 4B) .
Erk Pathway Inhibitor (PD-98059) Prevents Cardioprotective Effect of G1 After Ischemia-Reperfusion
We investigated whether Erk signaling is involved in GPERmediated cardioprotection as a mechanism leading to the inhibition of mPTP opening by using PD-98059 (5 M), a known blocker of Erk signaling.
PD-98059 prevents the improvement of the heart function recovery and the reduction of infarct size caused by G1 treatment after ischemia-reperfusion (Figs. 5-7) . Heart function recovery was much lower in heart perfused with G1 ϩ PD-98059 compared with G1 alone: RPP 4,421 Ϯ 76 vs. 9,420 Ϯ 264 (beats ⅐mmHg Ϫ1 ⅐min Ϫ1 , n ϭ 3 P Ͻ 0.01) (Fig.  6A) , dP/dt max 927 Ϯ 138 vs. 1,695 Ϯ 128 mmHg/s (P Ͻ 0.01, n ϭ 3/group) (Fig. 6B) , and ϪdP/dt min Ϫ506 Ϯ 53 vs. Ϫ762 Ϯ 86 mmHg/s (P Ͻ 0.05, n ϭ 3group) (Fig. 6C) . The infarct size increased in the G1 ϩ PD-98059 group (53 Ϯ 4 vs. 20 Ϯ 2%) compared with the G1-treated group (n ϭ 3 P Ͻ 0.01) (Fig. 7) . The mitochondrial CRC was reduced in the G1 ϩ PD-98059 group compared with the G1-treated group (1.4 Ϯ 0.2 vs. 2.4 Ϯ 0.1 M/mg mitochondrial proteins, n ϭ 3 P Ͻ 0.01, Fig. 8 ). These data strongly support the involvement of Erk pathway in the cardioprotective action of G1.
DISCUSSION
In this study, we report that the activation of GPER by the specific agonist GPER protects the heart against ischemiareperfusion injury, inhibiting Ca 2ϩ -induced mPTP opening. GPER has been shown to be localized in the endoplasmic reticulum (28, 32) and plasma membrane (11) of reproductive organs, uterus, and mammary gland as well as in the hippocampal regions (25) . Our results show the expression of GPER both at the mRNA and protein levels in the mouse adult heart. Recently, activation of GPER by acute infusion of G1 has been shown to be involved in reduction of mean arterial blood pressure (17) . Haas and coworkers (17) concluded that GPER contributes to regulation of blood pressure and vascular tone, suggesting the possibility that some of the known vasculoprotective effects of estrogen involve GPER activation. Here, we found that the acute G1 treatment significantly reduced the infarct size after ischemia-reperfusion. In a similar manner, acute treatment of 17␤-estradiol (40 nM) reduced the infarct size in male mouse isolated hearts (unpublished data) as previously reported by others (14, 36) . Thus the cardioprotective action of estrogen may involve the activation of GPER.
We have shown that acute G1 treatment considerably improves the cardiac function recovery after ischemia-reperfusion. Our data strongly support the view that activation of GPER induces a cardioprotection effect against ischemiareperfusion injury. Similarly, a recent report showed that G1 treatment of isolated rat heart is cardioprotective during ischemia-reperfusion (10).
Crompton et al.'s (8) laboratory, in the late 1980s, first proposed the role of the mPTP as a mediator of lethal ischemiareperfusion injury. The role of mPTP opening in ischemiareperfusion was later confirmed by other groups (19, 33) . Several studies have demonstrated the involvement of the inhibition of the mPTP in ischemic and pharmacological preconditioning (18, 30), postconditioning (2), and controlled reperfusion (5) . The mPTP opening occurred in response to Ca 2ϩ overload, oxidative stress, inorganic phosphate, and relative ATP depletion, conditions that are recreated during ischemia-reperfusion (8) , and cyclosporin A could inhibit mPTP opening and confer cardioprotection (9, 16) . In this study, we show that G1 treatment leads to mPTP opening inhibition after ischemia-reperfusion. This is the first observation linking the GPER and the mPTP opening. These results allow better understanding of the GPER activation-induced cardioprotection after ischemia-reperfusion. However, the mechanism through which the activation of GPER can cause the mPTP opening remains to be investigated.
It has been shown that the activation of Erk during ischemia and reperfusion plays an important role in modulation of the cardioprotection occurring by preconditioning (21) . Erk activation has been shown to result in inhibition of the mPTP installation (37) . Our results show that, in the presence of the Erk inhibitor PD-98059, G1 effect on the heart function recovery, infarct size, and the mitochondria CRC were all abolished. These data indicate that GPER activation by G1-induced cardioprotection is mediated by the Erk pathway, leading to the inhibition of mPTP opening. The participation of the Erk pathway in cardioprotection agrees with the recent findings that G1 treatment in rat heart increases Erk phosphorylation, which was prevented by PD-98059 (10). However, they did not observe a significant effect of PD-98059 in preventing G1 cardioprotection in heart function and in infarct size. The lack effect of PD-98059 on G1-induced cardioprotection could be tentatively explained by a relative short time (20 min) of ischemia used in the isolated rat heart subjected to ischemiareperfusion. In fact, in the rat model, 20 min of ischemia induced a small reversible functional damage subjected to variations of function recovery (29) .
In conclusion, the present study demonstrates that GPER activation improves cardiac functional recovery, induces reduction of infarct size, and inhibits the mPTP opening in isolated mice hearts subjected to ischemia-reperfusion. This cardioprotective effect of GPER activation is mediated by the Erk pathway. 
